Facebook
Twitter
LinkedIn
Forward162 Thoracic Oncology Tumor Board Conference (012822)
Dallas, TX US
January 28, 2022
The multidisciplinary approach, including the medical, surgical and radiation areas of cancer therapy, providing a forum for the comprehensive care of complex cases in the management of thoracic cancer patients.
Target Audience
Faculty, Fellows, Residents, particularly those involved in the treatment of thoracic cancer.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
1. Follow established guidelines for diagnosis of thoracic cancer patients
2. Incorporate multidisciplinary aspects in the care of thoracic cancer patients
3. Offer available clinical research protocols to thoracic cancer patients
UT Southwestern Medical Center
5323 Harry Hines Blvd.
ND3.218
Dallas, TX
75390
United States
Course Director(s)
John Waters, M.D.
has no relevant financial relationships to disclose at this time.
Moderator(s)
John Waters, M.D.
has no relevant financial relationships to disclose at this time.
Speaker(s)
Kiran Batra
has no relevant financial relationships to disclose at this time.
Jonathan Dowell
has a financial relationship (Professional Services) with astra zeneca;.
has a financial relationship (Professional Services) with Beigene;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Professional Services) with Genentech;.
David Gerber, MD
has a financial relationship (Grant Or Contract) with Sagimet;.
has a financial relationship (Independent contractor) with Sanofi;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Grant Or Contract) with BerGenBio;.
has a financial relationship (Independent contractor) with Catalyst Therapeutics;.
has a financial relationship (Grant Or Contract) with Karyopharm;.
has a financial relationship (Stock) with Gilead;.
has a financial relationship (Independent contractor) with Regeneron;.
Randall Hughes, M.D, Professor of Internal Medicine
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
Puneeth Iyengar, MD, PhD
has a financial relationship (Professional Services) with AZ;.
Asha Kandathil
has no relevant financial relationships to disclose at this time.
Fernando Kay, MD, PhD
has no relevant financial relationships to disclose at this time.
Kemp Kernstine, MD PhD
has no relevant financial relationships to disclose at this time.
VISHAL KUKKAR, MD
has no relevant financial relationships to disclose at this time.
Scott Reznik, MD
has a financial relationship (Stock) with Onconano ;.
Jennifer Schopp, MD
has no relevant financial relationships to disclose at this time.
Jose Torrealba, MD, Associate Professor
has no relevant financial relationships to disclose at this time.
Kenneth Westover, MD, PhD, Associate Professor of Radiation Oncology and Biochemistry
has a financial relationship (Independent contractor) with Amgen;.
has a financial relationship (Professional Services) with Vibliome Therapeutics;.
has a financial relationship (Grant Or Contract) with Revolution Medicines;.
Available Credit
- 1.00 AMA
- 1.00 Attendance
- 1.00 Ethics